A role for extensive SARS‐CoV‐2 virological assessment of donor and recipient in lung transplantation.

The article discusses the challenges posed by the COVID-19 pandemic in lung transplantation, focusing on the virological assessment of donors and recipients. It presents two detailed cases of lung transplantation involving a SARS-CoV-2 RNA-positive donor and a recipient, highlighting the complexities of decision-making in such scenarios. The study emphasizes the importance of comprehensive virological analyses in determining the risk of postoperative infection and the successful outcomes of lung transplantation despite SARS-CoV-2 RNA detection in donors or recipients. The research contributes valuable insights for future donor selection and transplantation protocols in the context of the pandemic. [Extracted from the article]